Tech Transfer eNews Blog

Oxford spinout develops MRI technology for earlier detection of Alzheimer’s


By Jesse Schwartz
Published: August 13th, 2019

An Oxford University spinout is developing a new technique for diagnosing Alzheimer’s disease from MRI scans.

Oxford Brain Diagnostics (OBD) is already connecting with pharmaceutical and biotech companies, which could use the technology to accelerate the development of effective new treatments for Alzheimer’s. The start-up’s overall goal is to enable doctors to detect the disease years earlier than current diagnostic methods, which only detect it after symptoms such as memory loss occur.

The diagnostic platform is based on combining MRI results with Cortical Disarray Measurement (CDM), a patented software-based analysis that uses algorithms created by the two co-founders, CEO Steven Chance Oxford Professor Mark Jenkinson. CDM analyses characteristics of the cerebral cortex of the brain.

Oxford University, the Oxford Technology and Innovations EIS Fund, RT Capital and other investors have contributed to OBD’s first funding round and provided industry expertise and contacts.

“We are very excited to make this technology available for real-world applications, helping others in the search for new effective drugs and to improve patients’ lives,” says Steven Chance, co-founder and CEO of OBD.

Mark Jenkinson, professor of neuroimaging at Oxford and co-founder of OBD, comments, “I am really looking forward to pushing the boundaries of the science behind our technique and exploring how it can help in the treatment and management of Alzheimer’s disease.”

Source: Mirage News

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment